- Price
- $32.16
- Day
- +4.35%
- Mkt Cap
- $7.17B
- 52W Range
- $13.74 – $65.30
- Volume
- 11.36M
- Beta
- 2.34
Find a company by name or ticker and open its page
Breaking news, press releases, and analyst updates.
Most recent articles and analysis covering this company.
New York, New York--(Newsfile Corp. - August 3, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Hims & Hers Health, Inc. ("Hims & Hers" or the "Company") (NYSE: HIMS). CLICK HERE TO RECEIVE MORE INFORMATION ABOUT THIS INVESTIGATION If you are a Hims & Hers investor and have suffered losses, or if you have information that could assist in the Hims & Hers investigation, you may CLICK HERE to contact us.
Read full article
In the past 12 months, the stock has nosedived more than 50%.
Read full article
RADNOR, Pa.--(BUSINESS WIRE)-- #classaction--Kessler Topaz Meltzer & Check, LLP (www.ktmc.com), a nationally recognized securities litigation law firm, is investigating potential violations of the federal securities laws by Hims & Hers Health, Inc. (NYSE: HIMS) on behalf of investors who purchased or acquired Hims & Hers Health, Inc. securities and experienced significant financial losses. HIMS Sued By the Federal Trade Commission On July 29, 2026, the Federal Trade Commission (“FTC”) filed a laws.
Read full article
Raul Shah (@Raul_DSF ) CEO of DocShah Financial, analyzes the potential Wall Street implications of the FDA's impending decision on peptide regulation, takes a closer look at how Hims & Hers could benefit from approval and shares his health care sector insights. Raul also explains why he still believes in UnitedHealth and why he'll always be a value investor.
Read full article
Hims & Hers Health Inc. (NYSE:HIMS) shares are trading higher on Friday as traders continue to weigh fresh regulatory scrutiny against a generally risk-on tape. Here's what investors need to know.
Read full article
/PRNewswire/ -- Schall, Brown and Schwartz LLP ("SBS"), a national shareholder rights litigation firm, announces that it is investigating claims on behalf of
Read full article
BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces an investigation on behalf of Hims & Hers Health, Inc. (“Hims” or the “Company”) (NYSE: HIMS) investors concerning the Company's possible violations of federal securities laws.IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN HIMS & HERS HEALTH, INC. (HIMS), CONTACT THE LAW OFFICES OF HOWARD G. SMITH ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS.Contact the Law Offices of Howard G. Smith to discuss your legal r.
Read full article
New York, New York--(Newsfile Corp. - July 30, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Hims & Hers Health, Inc. ("Hims & Hers" or the "Company") (NYSE: HIMS). CLICK HERE TO RECEIVE MORE INFORMATION ABOUT THIS INVESTIGATION If you are a Hims & Hers investor and have suffered losses, or if you have information that could assist in the Hims & Hers investigation, you may CLICK HERE to contact us.
Read full article
[url="]Glancy Prongay Wolke and Rotter LLP[/url], a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf
Read full article
Law Offices of Howard G. Smith announces an investigation on behalf of Hims and Hers Health, Inc. (âHimsâ or the âCompanyâ) (NYSE: [url="]HIMS[/url]) inve
Read full article
LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Hims & Hers Health, Inc. (“Hims” or the “Company”) (NYSE: HIMS) investors concerning the Company's possible violations of the federal securities laws.IF YOU ARE AN INVESTOR WHO LOST MONEY ON HIMS & HERS HEALTH, INC. (HIMS), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS.What H.
Read full article
LOS ANGELES--(BUSINESS WIRE)---- $HIMS--HIMS Investors Have Opportunity to Join Hims & Hers Health, Inc. Fraud Investigation with SBS Law.
Read full article